Skip to main content


Fig. 10 | Theoretical Biology and Medical Modelling

Fig. 10

From: A patient-specific treatment model for Graves’ hyperthyroidism

Fig. 10

After the oral administration of loading dosage = 30 mg/day (for 60 days) and maintenance dosage =10 mg/day (for 120 days), patient’s FT4 levels reaches closer to lower normal reference limit, so MMI dosage is lowered to 5 mg/day for 20 days. This in turn increased the levels of FT4 and then maintenance dosage continued for another 120 days

Back to article page